US Legal Cannabis Is Back on Pace for $30 Billion in 2026, One Year After Its First Decline

Legal cannabis in the United States is on track to sell about $30 billion in 2026. That would put the market back where it was in 2024, before 2025 became the first year in its history to shrink.

The recovery isn't coming from higher prices. Prices are still falling. It's coming from a handful of states that are still opening stores, and from medical programs in states that never legalized adult use.

Where the market is after 12 years

Whitney has the US regulated market growing every year from 2014, when Colorado and Washington opened the first adult-use stores and the whole country sold about $3.5 billion, through 2024, when it reached $30.1 billion. That was 11 straight years of growth.

Then 2025 fell to $29.1 billion, down about 3%. I wrote about why in US Legal Cannabis Sales Fell 3% in 2025, the First Annual Drop on Record, as Prices Sank: too much supply, falling prices, hemp-derived THC sold outside the system. Whitney said its own forecast accuracy, which had always been in the mid-to-high 90s, dropped to 85% that year, and it rebuilt its model to weigh price compression more heavily.

The firm's March release says 2026 will grow again, to $30.5 billion. It had once projected 13.4% growth for this year. It now expects single-digit growth to be the norm.

Whitney's March release doesn't restate the 2025 total. The $29.1 billion comes from its June jobs report with Vangst, as reported by NORML.

What 2026 looks like so far

The monthly numbers back the forecast up. The Marijuana Herald, which adds up state regulator reports each month, counted nearly $2.5 billion in June and about $14 billion for the first half. July came in at roughly $2.56 billion, the highest monthly total it has tracked and 10% above July 2025, though Minnesota and Delaware weren't selling yet a year ago. Seven months in, the running total was about $16.6 billion.

Straight-line that and you land at $28.5 billion. Add a normal fourth quarter, which runs above average because of the holidays, and $29 to $30 billion is the realistic range. That's Whitney's number, give or take.

California is still the biggest market at about $333 million in July, with Michigan second at $261 million. Both are shrinking. In Headset's data, California is down 1.8% and Michigan down 4.2% over the 12 months to September.

Who's carrying the growth

Two states. Whitney said the national decline in 2025 would have been steeper without New York and Ohio, and the same two are carrying 2026.

Headset has New York at $1.86 billion over the 12 months to September, up 22.1%, and Ohio at $1.30 billion, up 26.7%. Nothing else comes close. New Jersey, which was the growth story two years ago, is up 1.7%. Florida, a medical-only state, is up 3.8%.

Both New York and Ohio are young markets that are still adding stores and still pulling buyers out of the illicit market. Whitney's March note says that kind of conversion slows as a market matures. The West Coast shows what mature looks like: California, Oregon, Washington, and Nevada all shrank.

The medical markets

Medical cannabis is a bigger piece of the national number than most people assume, and it behaves differently depending on whether a state has adult-use sales.

Where adult-use exists, medical shrinks fast. New Jersey's medical sales fell from $226 million in 2022, the year adult-use launched, to $46 million in 2025. New York's medical program is under 3% of state sales; in September it did $4.8 million against $163 million in adult-use.

Where adult-use doesn't exist, medical is the whole market, and it's big. Florida sold $1.65 billion of medical cannabis in 2025 and set a monthly record of $198.2 million in July 2026, with 942,952 active patients and 782 dispensaries as of October 16. Headset has the state at $1.98 billion over the 12 months to September. Pennsylvania sold about $1.3 billion through the first three quarters of 2025 with about 439,400 patients, per Axios. Those two states alone are roughly a tenth of the US market, and neither has sold a gram to a recreational customer.

The best available national split is from a year-end piece in Cannabis Science and Technology that put 2025 at $23.9 billion adult-use and $7.6 billion medical. That article ran before the year closed and its total doesn't match Whitney's, so treat the ratio as a rough guide: medical is somewhere around a quarter of legal sales.

That's also why the Florida ballot matters nationally. Florida's adult-use campaign failed to make the 2026 ballot, so the biggest medical market in the country stays medical-only unless the legislature acts, with the next ballot chance in 2028.

The $47 billion number

You'll see a much bigger figure for 2026 in some places. Statista projects about $47 billion for US cannabis this year. That definition adds pharmaceutical cannabis and CBD products, and it isn't comparable to the regulated-retail series above. When someone tells you the US cannabis market is $47 billion, ask what they're counting.

What to watch

Whitney's next annual estimate, which will settle 2026, arrives early next year. Between now and then, three things decide whether the market lands above or below $30 billion: whether New York keeps opening stores at the pace it has, whether the December 11 federal hemp-THC cap pushes any hemp buyers back into dispensaries, and whether the West Coast decline flattens out. Prices aren't going to help. They're still falling.

Related: US Legal Cannabis Sales Fell 3% in 2025, the First Annual Drop on Record, as Prices Sank